Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1986 1
1988 1
1990 1
1991 1
1993 3
1994 2
1995 1
1999 2
2001 1
2002 4
2003 1
2004 2
2005 1
2007 2
2009 2
2010 1
2011 7
2012 6
2013 4
2014 3
2015 3
2017 6
2018 5
2019 1
2020 5
2021 1
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Pembrolizumab for Early-Stage Non-Small-Cell Lung Cancer.
Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, Chen KN, Dooms C, Majem M, Eigendorff E, Martinengo GL, Bylicki O, Rodríguez-Abreu D, Chaft JE, Novello S, Yang J, Keller SM, Samkari A, Spicer JD; KEYNOTE-671 Investigators. Wakelee H, et al. N Engl J Med. 2023 Aug 10;389(6):491-503. doi: 10.1056/NEJMoa2302983. Epub 2023 Jun 3. N Engl J Med. 2023. PMID: 37272513 Clinical Trial.
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer.
Wu YL, Tsuboi M, He J, John T, Grohe C, Majem M, Goldman JW, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Zeng L, Hodge R, Atasoy A, Rukazenkov Y, Herbst RS; ADAURA Investigators. Wu YL, et al. N Engl J Med. 2020 Oct 29;383(18):1711-1723. doi: 10.1056/NEJMoa2027071. Epub 2020 Sep 19. N Engl J Med. 2020. PMID: 32955177 Clinical Trial.
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Paz-Ares L, Luft A, Vicente D, Tafreshi A, Gümüş M, Mazières J, Hermes B, Çay Şenler F, Csőszi T, Fülöp A, Rodríguez-Cid J, Wilson J, Sugawara S, Kato T, Lee KH, Cheng Y, Novello S, Halmos B, Li X, Lubiniecki GM, Piperdi B, Kowalski DM; KEYNOTE-407 Investigators. Paz-Ares L, et al. N Engl J Med. 2018 Nov 22;379(21):2040-2051. doi: 10.1056/NEJMoa1810865. Epub 2018 Sep 25. N Engl J Med. 2018. PMID: 30280635 Free article. Clinical Trial.
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.
Vascular emergencies in neuro-ophthalmology.
Iorga ER, Costin D. Iorga ER, et al. Among authors: costin d. Rom J Ophthalmol. 2020 Oct-Dec;64(4):323-332. doi: 10.22336/rjo.2020.54. Rom J Ophthalmol. 2020. PMID: 33367170 Free PMC article. Review.
The Optimal Management of Neisseria gonorrhoeae Infections.
Ursu RG, Luchian I, Damian C, Porumb-Andrese E, Cobzaru RG, Nichitean G, Ripa C, Costin D, Sandu D, Andrioaie IM, Iancu LS. Ursu RG, et al. Among authors: costin d. Microorganisms. 2022 Dec 1;10(12):2388. doi: 10.3390/microorganisms10122388. Microorganisms. 2022. PMID: 36557641 Free PMC article. Review.
Current trends in gene therapy for retinal diseases (Review).
Moraru AD, Costin D, Iorga RE, Munteanu M, Moraru RL, Branisteanu DC. Moraru AD, et al. Among authors: costin d. Exp Ther Med. 2022 Jan;23(1):26. doi: 10.3892/etm.2021.10948. Epub 2021 Nov 5. Exp Ther Med. 2022. PMID: 34815778 Free PMC article. Review.
74 results